Trial Profile
Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Filgotinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Proof of concept; Therapeutic Use
- Sponsors Galapagos NV
- 13 Jun 2015 Results assessing gene signature presented at the 16th Annual Congress of the European League Against Rheumatism.
- 30 Oct 2013 Results assessing pharmacodynamic parameters and metabolite pharmacokinetics presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.